Preclinical toxicologic studies of netilmicin

Area of Science:

• Pharmacology
• Toxicology
• Drug Safety

Background:

• Aminoglycoside antibiotics are crucial for treating bacterial infections.
• Understanding the toxicological profile of new aminoglycosides is essential for clinical use.

Purpose of the Study:

• To evaluate the toxicological effects of 1-N-Ethylsisomicin (netilmicin) in various animal models.
• To compare the safety profile of netilmicin with other established aminoglycosides, particularly regarding nephrotoxicity.

Main Methods:

• Parenteral administration of netilmicin to mice, rats, guinea pigs, rabbits, and dogs.
• Acute and subchronic toxicity studies, including reproductive and developmental assessments.
• Comparative nephrotoxicity studies with tobramycin, gentamicin, and kanamycin in rats and dogs.

Main Results:

• Acute toxicity signs were primarily neuromuscular blockade.
• No teratogenic effects or adverse impacts on fertility, reproduction, or offspring development were observed.
• Netilmicin exhibited less nephrotoxicity in rats compared to tobramycin and gentamicin, and similar or slightly higher than kanamycin.
• Renal effects in dogs were mild, and at high multiples of human therapeutic doses, netilmicin's renal effects were significantly less severe than gentamicin's.

Conclusions:

• 1-N-Ethylsisomicin (netilmicin) possesses a favorable toxicological profile with minimal reproductive and developmental toxicity.
• Netilmicin demonstrates a reduced nephrotoxic potential compared to other widely used aminoglycosides, suggesting a potentially safer therapeutic option.